BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 10945611)

  • 1. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
    Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A; Fisher AM; Rucker N; Gomer CJ
    Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
    Fang J; Yan L; Shing Y; Moses MA
    Cancer Res; 2001 Aug; 61(15):5731-5. PubMed ID: 11479208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death.
    Kotch LE; Iyer NV; Laughner E; Semenza GL
    Dev Biol; 1999 May; 209(2):254-67. PubMed ID: 10328919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
    Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
    Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
    Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.
    Jiang BH; Agani F; Passaniti A; Semenza GL
    Cancer Res; 1997 Dec; 57(23):5328-35. PubMed ID: 9393757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells.
    Horiuchi A; Imai T; Shimizu M; Oka K; Wang C; Nikaido T; Konishi I
    Anticancer Res; 2002; 22(5):2697-702. PubMed ID: 12529984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
    Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E
    Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1.
    Liu LX; Lu H; Luo Y; Date T; Belanger AJ; Vincent KA; Akita GY; Goldberg M; Cheng SH; Gregory RJ; Jiang C
    Biochem Biophys Res Commun; 2002 Mar; 291(4):908-14. PubMed ID: 11866451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.
    Damert A; Machein M; Breier G; Fujita MQ; Hanahan D; Risau W; Plate KH
    Cancer Res; 1997 Sep; 57(17):3860-4. PubMed ID: 9288800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.
    Gomer CJ; Ferrario A; Luna M; Rucker N; Wong S
    Lasers Surg Med; 2006 Jun; 38(5):516-21. PubMed ID: 16607618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
    Solban N; Selbo PK; Sinha AK; Chang SK; Hasan T
    Cancer Res; 2006 Jun; 66(11):5633-40. PubMed ID: 16740700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
    Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.